Forte Biosciences, Inc. (FBRX): Price and Financial Metrics
GET POWR RATINGS... FREE!
FBRX Stock Price Chart Interactive Chart >
FBRX Price/Volume Stats
| Current price | $1.29 | 52-week high | $7.26 |
| Prev. close | $1.20 | 52-week low | $1.03 |
| Day low | $1.18 | Volume | 102,900 |
| Day high | $1.30 | Avg. volume | 191,023 |
| 50-day MA | $1.33 | Dividend yield | N/A |
| 200-day MA | $2.28 | Market Cap | 19.04M |
Forte Biosciences, Inc. (FBRX) Company Bio
Forte Biosciences Inc. operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California.
Latest FBRX News From Around the Web
Below are the latest news stories about Forte Biosciences Inc that investors may wish to consider to help them evaluate FBRX as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayGood morning! |
Following Its 52-Week Low, Forte Biosciences Inc. (NASDAQ: FBRX)’S Share Price Rose 8.41% And Its YTD Numbers Fell -94.12%During the last session, Forte Biosciences Inc. (NASDAQ:FBRX)’s traded shares were 3.02 million, with the beta value of the company hitting 0.67. At the end of the trading day, the stock’s price was $2.14, reflecting an intraday gain of 5.94% or $0.12. The 52-week high for the FBRX share is $43.57, that puts it down … Following Its 52-Week Low, Forte Biosciences Inc. (NASDAQ: FBRX)’S Share Price Rose 8.41% And Its YTD Numbers Fell -94.12% Read More » |
Here's Why We're Watching Forte Biosciences' (NASDAQ:FBRX) Cash Burn SituationEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
Forte Biosciences, Inc. (NASDAQ:FBRX) Expected to Post Earnings of -$0.38 Per ShareWall Street analysts predict that Forte Biosciences, Inc. (NASDAQ:FBRX) will post earnings of ($0.38) per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Forte Biosciences earnings. The business is scheduled to announce its next quarterly earnings results on Wednesday, March 23rd. According to Zacks, analysts expect that Forte Biosciences will [] |
Forte Biosciences Inc. (FBRX) At $2.24: Is It Worth Your Interest?Forte Biosciences Inc. (NASDAQ:FBRX) concluded the trading at $2.24 on Friday, December 03 with a fall of -7.44% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.42 with its price kept floating in the range of $2.22 and $2.42 on the Forte Biosciences Inc. (FBRX) At $2.24: Is It Worth Your Interest? Read More » |
FBRX Price Returns
| 1-mo | 4.88% |
| 3-mo | -2.27% |
| 6-mo | -50.95% |
| 1-year | -78.22% |
| 3-year | -87.77% |
| 5-year | -96.84% |
| YTD | -39.72% |
| 2021 | -64.73% |
| 2020 | 355.24% |
| 2019 | -93.51% |
| 2018 | -19.90% |
| 2017 | N/A |
Loading social stream, please wait...